REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2023

Primary Completion Date

September 1, 2025

Study Completion Date

December 1, 2025

Conditions

Diabetes Mellitus, Type 2Peripheral Arterial Disease

Interventions

BIOLOGICAL

MEI6570

Saline Control

Trial Locations (1)

Prof Derek J. Hausenloy, Singapore

All Listed Sponsors

collaborator

Singapore General Hospital

OTHER

collaborator

Khoo Teck Puat Hospital

OTHER

collaborator

National University Health System, Singapore

OTHER

lead

National Heart Centre Singapore

OTHER

NCT05912218 - REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD | Biotech Hunter | Biotech Hunter